- Home
- Press
- Press Releases
Bayer CropScience and Chromatin Inc. launch mini-chromosome technology alliance
Thursday, August 20, 2009
Strengthening research and development:
Bayer CropScience and Chromatin Inc. launch mini-chromosome technology alliance
Monheim, August 20, 2009 – Bayer CropScience and Chromatin Inc. (Chicago, Illinois) announced today that they have entered into a technological alliance and license agreement to use Chromatin’s proprietary mini-chromosome technology for crop improvement.
Chromatin has developed a novel approach to gene stacking, using plant DNA to deliver several genes on a single chromosome. Under the agreement, Bayer CropScience has obtained non-exclusive rights to use Chromatin’s technology to introduce Bayer’s high-value trait genes into cotton. Bayer CropScience also obtained options to expand this program to other crops. Further terms of the deal were not disclosed.
Dr. Linda Trolinder, Global Cotton R&D Manager at BioScience, a business operations unit of Bayer CropScience, welcomes the new business relationship with Chromatin: "Bayer CropScience is committed to offering top-of-the-line innovation to its customers, and Chromatin's technology enables the use of new approaches and more flexibility in research which will facilitate the speed with which we bring our products to customers.”
“Chromatin is pleased to partner with Bayer CropScience, who, with its FiberMax® brand and other technologies, is a leader in the development of new cotton varieties worldwide,” said Daphne Preuss, Chromatin’s Chief Executive Officer. “We look forward to working with Bayer CropScience to develop the next generation of crops with high-value yield and quality traits.”
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.4 billion (2008), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of more than 18,000 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
About Chromatin
Chromatin Inc. develops and markets novel proprietary technology that enables entire chromosomes to be designed and incorporated into plant cells. These mini-chromosomes can be used in any plant to simultaneously introduce multiple genes while maintaining precise control of gene expression. Chromatin’s mini-chromosome technology can be used to deliver genes that benefit the agricultural, nutritional, energy, pharmaceutical, and chemical sectors. For additional information visit www.chromatininc.com.
Contact:
Bayer CropScience: Richard Breum, phone: +49 2173 38-3270
E-mail: richard.breum@bayercropscience.com
Chromatin: Daphne Preuss, phone +1 312-515-1060
E-mail: dpreuss@chromatininc.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Chromatin has developed a novel approach to gene stacking, using plant DNA to deliver several genes on a single chromosome. Under the agreement, Bayer CropScience has obtained non-exclusive rights to use Chromatin’s technology to introduce Bayer’s high-value trait genes into cotton. Bayer CropScience also obtained options to expand this program to other crops. Further terms of the deal were not disclosed.
Dr. Linda Trolinder, Global Cotton R&D Manager at BioScience, a business operations unit of Bayer CropScience, welcomes the new business relationship with Chromatin: "Bayer CropScience is committed to offering top-of-the-line innovation to its customers, and Chromatin's technology enables the use of new approaches and more flexibility in research which will facilitate the speed with which we bring our products to customers.”
“Chromatin is pleased to partner with Bayer CropScience, who, with its FiberMax® brand and other technologies, is a leader in the development of new cotton varieties worldwide,” said Daphne Preuss, Chromatin’s Chief Executive Officer. “We look forward to working with Bayer CropScience to develop the next generation of crops with high-value yield and quality traits.”
About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.4 billion (2008), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and plant biotechnology. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of more than 18,000 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.
About Chromatin
Chromatin Inc. develops and markets novel proprietary technology that enables entire chromosomes to be designed and incorporated into plant cells. These mini-chromosomes can be used in any plant to simultaneously introduce multiple genes while maintaining precise control of gene expression. Chromatin’s mini-chromosome technology can be used to deliver genes that benefit the agricultural, nutritional, energy, pharmaceutical, and chemical sectors. For additional information visit www.chromatininc.com.
Contact:
Bayer CropScience: Richard Breum, phone: +49 2173 38-3270
E-mail: richard.breum@bayercropscience.com
Chromatin: Daphne Preuss, phone +1 312-515-1060
E-mail: dpreuss@chromatininc.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
Social Media 
Social Media
[ last update: Thursday, January 7, 2010 ]
